VIST vs. ZVRA
VIST (Vista Energy, S.A.B. de C.V.) and ZVRA (Zevra Therapeutics Inc.) are both stocks. VIST operates in Oil & Gas E&P (Energy), while ZVRA operates in Biotechnology (Healthcare). Over the past 5 years, VIST returned 71.42%/yr vs -1.18%/yr for ZVRA. Their 0.14 correlation means their historical movements had little consistent relationship.
Performance
VIST vs. ZVRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VIST achieves a 44.78% return, which is significantly higher than ZVRA's 6.14% return.
VIST
- 1D
- 2.74%
- 1M
- 12.38%
- 6M
- 16.47%
- YTD
- 44.78%
- 1Y
- 57.61%
- 3Y*
- 39.75%
- 5Y*
- 71.42%
- 10Y*
- —
- ALL TIME*
- 35.77%
ZVRA
- 1D
- -1.35%
- 1M
- -31.14%
- 6M
- 5.67%
- YTD
- 6.14%
- 1Y
- -14.40%
- 3Y*
- 24.74%
- 5Y*
- -1.18%
- 10Y*
- -17.62%
- ALL TIME*
- -23.23%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $67.07M | $65.42M | $69.21M | |
| $18.33M | $18.68M | $21.76M |
VIST vs. ZVRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
VIST Vista Energy, S.A.B. de C.V. | 44.78% | -10.07% | 83.36% | 88.44% | 193.81% | 108.20% | -67.39% | -4.85% |
ZVRA Zevra Therapeutics Inc. | 6.14% | 7.43% | 27.33% | 42.70% | -47.30% | -22.23% | 84.70% | -72.93% |
Correlation
The correlation between VIST and ZVRA is 0.04, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.04 |
Correlation (3Y) Balances recent behavior with more history. | 0.13 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.13 |
Correlation (All Time) Calculated using the full available price history since Jul 26, 2019 | 0.14 |
Fundamentals
VIST:
$7.35B
ZVRA:
$562.18M
VIST:
$7.61
ZVRA:
$2.15
VIST:
9.26
ZVRA:
4.43
VIST:
2.21
ZVRA:
4.50
VIST:
2.42
ZVRA:
2.78
VIST:
$3.53B
ZVRA:
$122.29M
VIST:
$1.74B
ZVRA:
$104.94M
VIST:
$2.39B
ZVRA:
$149.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VIST vs. ZVRA — Risk / Return Rank
VIST
ZVRA
VIST vs. ZVRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Vista Energy, S.A.B. de C.V. (VIST) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VIST | ZVRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.38 | ||
| Sortino ratioReturn per unit of downside risk | +1.70 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.02 | +0.21 |
| Calmar ratioReturn relative to maximum drawdown | 2.22 | -0.36 | +2.57 |
| Martin ratioReturn relative to average drawdown | 4.72 | -0.65 | +5.37 |
Loading charts...
Drawdowns
VIST vs. ZVRA - Drawdown Comparison
The maximum VIST drawdown since its inception was -81.19%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for VIST and ZVRA.
Loading charts...
Drawdown Indicators
| VIST | ZVRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.19% | -99.27% | +18.08% |
Max Drawdown (1Y)Largest decline over 1 year | -26.13% | -40.40% | +14.27% |
Max Drawdown (3Y)Largest decline over 3 years | -43.36% | -43.47% | +0.11% |
Max Drawdown (5Y)Largest decline over 5 years | -43.36% | -60.97% | +17.61% |
Max Drawdown (10Y)Largest decline over 10 years | — | -97.85% | — |
Current DrawdownCurrent decline from peak | -11.10% | -97.48% | +86.38% |
Average DrawdownAverage peak-to-trough decline | -28.02% | -86.53% | +58.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.25% | 22.22% | -9.97% |
Volatility
VIST vs. ZVRA - Volatility Comparison
The current volatility for Vista Energy, S.A.B. de C.V. (VIST) is 12.90%, while Zevra Therapeutics Inc. (ZVRA) has a volatility of 29.44%. This indicates that VIST experiences smaller price fluctuations and is considered to be less risky than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VIST | ZVRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.90% | 29.44% | -16.54% |
Volatility (6M)Calculated over the trailing 6-month period | 32.64% | 49.17% | -16.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.98% | 65.35% | -15.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 51.40% | 61.11% | -9.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.79% | 81.05% | -20.26% |
Dividends
VIST vs. ZVRA - Dividend Comparison
Neither VIST nor ZVRA has paid dividends to shareholders.
Financials
VIST vs. ZVRA - Financials Comparison
This section allows you to compare key financial metrics between Vista Energy, S.A.B. de C.V. and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
VIST and ZVRA have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZVRA has higher volatility (29.44%) compared to VIST (12.90%). In terms of maximum drawdown, VIST dropped -81.19% vs ZVRA's -99.27%.
VIST currently has the higher Sharpe Ratio (1.16 vs -0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VIST and ZVRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer